CLINICAL-ANAMNESTICAL AND MOLECULAR GENETIC FACTORS OF PREECLAMPSIA AND THEIR ASSOCIATION TO THE COURSE AND OUTCOME OF PREGNANCY

Authors

  • Makhmudova Sevara Erkinovna

Keywords:

Preeclampsia, placental growth factor, genetics, pregnancy, proteinuria, trophoblast, C-section, placenta

Abstract

Preeclampsia (PE) is a disease that continues to be the main cause of maternal and fetal mortality and complications in 5-8% of pregnancies, Preeclampsia develops after 20 weeks of pregnancy and is characterized by hypertension and proteinuria. According to WHO, hypertension during pregnancy is the cause of 9 to 25 per cent of all maternal mortality, but accurate data are difficult to determine. In addition to the fact that PH is one of the leading causes of maternal and perinatal mortality, this disease and its complications cause a range of medical problems. There are still no new early methods for predicting preeclampsia. Preeclampsia is defined as hypertension and proteinuria in the second half of pregnancy and is one of the most complex diseases known in obstetrics. Although there is now some progress in the discovery of the pathophysiology of preeclampsia, conflicting theories still exist and the debate is certainly relevant. According to WHO, one in five children born to a mother with pre-eclampsia has impaired physical and psycho-emotional development, with higher morbidity rates in infancy and early childhood.

References

Акуленко А.В., Цахилова С.Г., Дзансолова А.В., Сарахова Д.Х., Кокоева Ф.Б., Кравцова М.Е. Роль полиморфизма генов ренин-ангиотензиновой системы в этиологии и патогенезе преэклампсии //Проблемы репродукции, 2015.-N 1.-С.8-11.

Акуденко А.В., Дзансолова А.В., Мугадова З.В., Балиос А.В., Созаева А.Г., Кузнецов В.М.

Персонифицированный подход к прогнозированию преэклампсии //Проблемы репродукции, 2017.-N 2.-С.84-87.

Аксенова А.С., Козиолова Н.А., Падруль М.М. Особенности течения гипертензивного синдрома и поражение органов-мишеней в зависимости от формы артериальной гипертензии у беременных //Уральский медицинский журнал, 2017.-N 6.-С.59-65

Костенко И.В., Оленко Е.С., Кодочигова А.И., Сушкова Н.В., Субботина В.Г., Делиникайтис Е.Г. Возможность развития преэклампсии у клинически здоровых женщин // Вестник медицинского института Реавиз, 2017.-N 1.-С.73-78

Лихачев, С.А. Неврологические проявления гестоза / С.А. Лихачев, А.В. Астапенко, Е.Л. Осос // Медицинские новости. — 2008. — № 14. — C.22—26.

Макулова М.В. Эндотелиальная дисфункция в патогенезе гестоза //Журнал акушерства и женских болезней, 2014.-N 6.-С.44-54.

Laganà AS, Vitale SG, Sapia F, Valenti G, Corrado F, Padula F, Rapisarda AMC, D'Anna R.miRNA expression for early diagnosis of preeclampsia onset: hope or hype?J Matern Fetal Neonatal Med. 2018 Mar;31(6):817-821.

Rahimi Z, Zangeneh M, Rezaeyan A, Shakiba E, Rahimi Z.MMP-8 C-799T and MMP-8 C+17G polymorphisms in mild and severe preeclampsia: Association between MMP-8 C-799T with susceptibility to severe preeclampsia.Clin Exp Hypertens. 2018;40(2):175-178. doi: 10.1080/10641963.2017.1346115. Epub 2017 Jul 26.

Strand K.M., Heimstad R., Iversen A.C. et al. Mediators of the association between pre-eclampsia and cerebral palsy: population based cohort study BMJ 2013; 347: 4089.

Williams D. Long-term complications of preeclampsia. Semin Nephrol 2011; 31: 1: 111—122.

Published

2021-05-28